A Managed Care Review of Schizophrenia: Evaluating Unmet Medical Needs, New Treatments, and Health Economics

A recent review emphasizes the need for personalized treatment strategies and a multidisciplinary approach to effectively manage the various subtypes of gastroesophageal reflux disease (GERD), highlighting the challenges of diagnosis and treatment, particularly in cases with refractory symptoms.

The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.

Here are 5 things individuals should know about the powerful impact of blood donation and the benefits becoming a donor can have for patients in need.

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.

The long-term safety of ibrutinib was proven in patients with newly diagnosed or relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).